According to Bristol-Myers Squibb's latest financial reports and stock price the company's current Operating Margin is 16.70%. At the end of 2021 the company had an Operating Margin of 17.46%.
Year | Operating Margin | Change |
---|---|---|
2021 | 17.46% | -208.03% |
2020 | -16.16% | -184.93% |
2019 | 19.03% | -28.07% |
2018 | 26.45% | 7.11% |
2017 | 24.70% | -18.89% |
2016 | 30.45% | 142.76% |
2015 | 12.54% | -16.36% |
2014 | 14.99% | -15.02% |
2013 | 17.64% | 32.87% |
2012 | 13.28% | -59.59% |
2011 | 32.86% | 5.46% |
2010 | 31.16% | 4.61% |
2009 | 29.79% | 12.13% |
2008 | 26.56% | 45.42% |
2007 | 18.27% | 24.18% |
2006 | 14.71% | -37.44% |
2005 | 23.51% | 3.14% |
2004 | 22.80% | 1.47% |
2003 | 22.47% | 53.78% |
2002 | 14.61% | -2.02% |
2001 | 14.91% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 24.28% | 45.39% | ๐บ๐ธ USA |
![]() Novartis NVS | 16.15% | -3.29% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 29.90% | 79.04% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 23.21% | 38.98% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 23.84% | 42.75% | ๐บ๐ธ USA |
![]() Amgen AMGN | 27.90% | 67.07% | ๐บ๐ธ USA |
![]() Sanofi SNY | 19.90% | 19.16% | ๐ซ๐ท France |
![]() Biogen BIIB | 35.30% | 111.38% | ๐บ๐ธ USA |
![]() Merck MRK | 28.49% | 70.60% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | -0.70% | -104.19% | ๐ฌ๐ง UK |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.